nodes	percent_of_prediction	percent_of_DWPC	metapath
Carfilzomib—ABCB1—Fluticasone furoate—asthma	0.0791	0.263	CbGbCtD
Carfilzomib—ABCB1—Indacaterol—asthma	0.0645	0.215	CbGbCtD
Carfilzomib—ABCB1—Loratadine—asthma	0.0344	0.115	CbGbCtD
Carfilzomib—ABCB1—Methylprednisolone—asthma	0.0315	0.105	CbGbCtD
Carfilzomib—ABCB1—Betamethasone—asthma	0.0205	0.0682	CbGbCtD
Carfilzomib—ABCB1—Prednisolone—asthma	0.0202	0.0673	CbGbCtD
Carfilzomib—ABCB1—Hydrocortisone—asthma	0.0191	0.0638	CbGbCtD
Carfilzomib—ABCB1—Prednisone—asthma	0.0191	0.0635	CbGbCtD
Carfilzomib—ABCB1—Dexamethasone—asthma	0.0119	0.0397	CbGbCtD
Carfilzomib—PSMB10—respiratory system—asthma	0.0113	0.0753	CbGeAlD
Carfilzomib—PSMB10—adrenal gland—asthma	0.00683	0.0456	CbGeAlD
Carfilzomib—PSMB8—adrenal cortex—asthma	0.0061	0.0407	CbGeAlD
Carfilzomib—PSMB10—lung—asthma	0.00599	0.04	CbGeAlD
Carfilzomib—PSMB8—bronchus—asthma	0.00598	0.0399	CbGeAlD
Carfilzomib—PSMB1—respiratory system—asthma	0.00561	0.0374	CbGeAlD
Carfilzomib—PSMB2—respiratory system—asthma	0.00547	0.0365	CbGeAlD
Carfilzomib—PSMB5—adrenal cortex—asthma	0.00539	0.0359	CbGeAlD
Carfilzomib—PSMB8—trachea—asthma	0.00537	0.0358	CbGeAlD
Carfilzomib—PSMB5—bronchus—asthma	0.00528	0.0353	CbGeAlD
Carfilzomib—PSMB5—smooth muscle tissue—asthma	0.00517	0.0345	CbGeAlD
Carfilzomib—PSMB5—trachea—asthma	0.00474	0.0317	CbGeAlD
Carfilzomib—PSMB1—adrenal cortex—asthma	0.00471	0.0314	CbGeAlD
Carfilzomib—PSMB1—bronchus—asthma	0.00462	0.0308	CbGeAlD
Carfilzomib—PSMB2—adrenal cortex—asthma	0.00459	0.0307	CbGeAlD
Carfilzomib—PSMB1—smooth muscle tissue—asthma	0.00452	0.0301	CbGeAlD
Carfilzomib—PSMB2—bronchus—asthma	0.00451	0.0301	CbGeAlD
Carfilzomib—PSMB2—smooth muscle tissue—asthma	0.00441	0.0294	CbGeAlD
Carfilzomib—PSMB8—adrenal gland—asthma	0.0044	0.0294	CbGeAlD
Carfilzomib—PSMB1—cardiovascular system—asthma	0.0043	0.0287	CbGeAlD
Carfilzomib—PSMB2—cardiovascular system—asthma	0.00419	0.028	CbGeAlD
Carfilzomib—PSMB1—trachea—asthma	0.00415	0.0277	CbGeAlD
Carfilzomib—PSMB2—trachea—asthma	0.00405	0.027	CbGeAlD
Carfilzomib—PSMB5—adrenal gland—asthma	0.00389	0.0259	CbGeAlD
Carfilzomib—PSMB8—lung—asthma	0.00386	0.0257	CbGeAlD
Carfilzomib—PSMB5—lung—asthma	0.00341	0.0227	CbGeAlD
Carfilzomib—PSMB1—adrenal gland—asthma	0.0034	0.0227	CbGeAlD
Carfilzomib—PSMB2—adrenal gland—asthma	0.00332	0.0221	CbGeAlD
Carfilzomib—PSMB1—lung—asthma	0.00298	0.0199	CbGeAlD
Carfilzomib—PSMB2—lung—asthma	0.00291	0.0194	CbGeAlD
Carfilzomib—ABCB1—respiratory system—asthma	0.000836	0.00558	CbGeAlD
Carfilzomib—ABCB1—adrenal cortex—asthma	0.000702	0.00468	CbGeAlD
Carfilzomib—ABCB1—epithelium—asthma	0.000699	0.00466	CbGeAlD
Carfilzomib—ABCB1—cardiovascular system—asthma	0.000641	0.00427	CbGeAlD
Carfilzomib—ABCB1—trachea—asthma	0.000618	0.00412	CbGeAlD
Carfilzomib—ABCB1—adrenal gland—asthma	0.000507	0.00338	CbGeAlD
Carfilzomib—PSMB9—Betamethasone—Fluticasone furoate—asthma	0.000481	0.0434	CbGdCrCtD
Carfilzomib—PSMB9—Dexamethasone—Fluticasone furoate—asthma	0.000481	0.0434	CbGdCrCtD
Carfilzomib—PSMB9—Dexamethasone—Fluticasone Propionate—asthma	0.000449	0.0405	CbGdCrCtD
Carfilzomib—PSMB9—Betamethasone—Fluticasone Propionate—asthma	0.000449	0.0405	CbGdCrCtD
Carfilzomib—ABCB1—lung—asthma	0.000444	0.00296	CbGeAlD
Carfilzomib—Cough—Budesonide—asthma	0.000363	0.00119	CcSEcCtD
Carfilzomib—Infection—Montelukast—asthma	0.000362	0.00118	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Mometasone—asthma	0.000361	0.00118	CcSEcCtD
Carfilzomib—Hypertension—Budesonide—asthma	0.00036	0.00118	CcSEcCtD
Carfilzomib—Cardiac arrest—Triamcinolone—asthma	0.000358	0.00117	CcSEcCtD
Carfilzomib—Cardiac arrest—Methylprednisolone—asthma	0.000357	0.00117	CcSEcCtD
Carfilzomib—Thrombocytopenia—Montelukast—asthma	0.000356	0.00117	CcSEcCtD
Carfilzomib—Sepsis—Prednisone—asthma	0.000356	0.00116	CcSEcCtD
Carfilzomib—Arthralgia—Budesonide—asthma	0.000355	0.00116	CcSEcCtD
Carfilzomib—Dyspnoea—Mometasone—asthma	0.000353	0.00116	CcSEcCtD
Carfilzomib—Diarrhoea—Fluticasone Propionate—asthma	0.000353	0.00115	CcSEcCtD
Carfilzomib—Dizziness—Ipratropium bromide—asthma	0.000352	0.00115	CcSEcCtD
Carfilzomib—Diarrhoea—Salmeterol—asthma	0.000352	0.00115	CcSEcCtD
Carfilzomib—Infection—Salbutamol—asthma	0.000349	0.00114	CcSEcCtD
Carfilzomib—Nausea—Cromoglicic acid—asthma	0.000346	0.00113	CcSEcCtD
Carfilzomib—Decreased appetite—Mometasone—asthma	0.000344	0.00113	CcSEcCtD
Carfilzomib—Fatigue—Mometasone—asthma	0.000341	0.00112	CcSEcCtD
Carfilzomib—Dizziness—Fluticasone Propionate—asthma	0.000341	0.00112	CcSEcCtD
Carfilzomib—Dizziness—Salmeterol—asthma	0.00034	0.00111	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Arformoterol—asthma	0.000339	0.00111	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Formoterol—asthma	0.000339	0.00111	CcSEcCtD
Carfilzomib—Vomiting—Ipratropium bromide—asthma	0.000339	0.00111	CcSEcCtD
Carfilzomib—Pain—Mometasone—asthma	0.000338	0.00111	CcSEcCtD
Carfilzomib—Infection—Budesonide—asthma	0.000338	0.00111	CcSEcCtD
Carfilzomib—Body temperature increased—Flunisolide—asthma	0.000337	0.0011	CcSEcCtD
Carfilzomib—Insomnia—Arformoterol—asthma	0.000336	0.0011	CcSEcCtD
Carfilzomib—Insomnia—Formoterol—asthma	0.000336	0.0011	CcSEcCtD
Carfilzomib—Anorexia—Salbutamol—asthma	0.000334	0.0011	CcSEcCtD
Carfilzomib—Diarrhoea—Aminophylline—asthma	0.000334	0.00109	CcSEcCtD
Carfilzomib—Headache—Ipratropium bromide—asthma	0.000334	0.00109	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Montelukast—asthma	0.000332	0.00109	CcSEcCtD
Carfilzomib—Dyspnoea—Arformoterol—asthma	0.000331	0.00108	CcSEcCtD
Carfilzomib—Dyspnoea—Formoterol—asthma	0.000331	0.00108	CcSEcCtD
Carfilzomib—Asthenia—Loratadine—asthma	0.000331	0.00108	CcSEcCtD
Carfilzomib—PSMB9—Dexamethasone—Beclomethasone—asthma	0.00033	0.0298	CbGdCrCtD
Carfilzomib—PSMB9—Betamethasone—Beclomethasone—asthma	0.00033	0.0298	CbGdCrCtD
Carfilzomib—Insomnia—Montelukast—asthma	0.000329	0.00108	CcSEcCtD
Carfilzomib—Cardiac failure congestive—Prednisone—asthma	0.000328	0.00107	CcSEcCtD
Carfilzomib—Vomiting—Fluticasone Propionate—asthma	0.000328	0.00107	CcSEcCtD
Carfilzomib—Vomiting—Salmeterol—asthma	0.000327	0.00107	CcSEcCtD
Carfilzomib—Cardiac arrest—Betamethasone—asthma	0.000325	0.00106	CcSEcCtD
Carfilzomib—Cardiac arrest—Dexamethasone—asthma	0.000325	0.00106	CcSEcCtD
Carfilzomib—Anorexia—Budesonide—asthma	0.000324	0.00106	CcSEcCtD
Carfilzomib—Dizziness—Aminophylline—asthma	0.000323	0.00106	CcSEcCtD
Carfilzomib—Headache—Fluticasone Propionate—asthma	0.000323	0.00106	CcSEcCtD
Carfilzomib—Headache—Salmeterol—asthma	0.000322	0.00105	CcSEcCtD
Carfilzomib—Upper respiratory tract infection—Hydrocortisone—asthma	0.000321	0.00105	CcSEcCtD
Carfilzomib—Fatigue—Arformoterol—asthma	0.00032	0.00105	CcSEcCtD
Carfilzomib—Fatigue—Formoterol—asthma	0.00032	0.00105	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Salbutamol—asthma	0.00032	0.00105	CcSEcCtD
Carfilzomib—Constipation—Arformoterol—asthma	0.000318	0.00104	CcSEcCtD
Carfilzomib—Constipation—Formoterol—asthma	0.000318	0.00104	CcSEcCtD
Carfilzomib—Pain—Arformoterol—asthma	0.000318	0.00104	CcSEcCtD
Carfilzomib—Pain—Formoterol—asthma	0.000318	0.00104	CcSEcCtD
Carfilzomib—Insomnia—Salbutamol—asthma	0.000317	0.00104	CcSEcCtD
Carfilzomib—Nausea—Ipratropium bromide—asthma	0.000316	0.00104	CcSEcCtD
Carfilzomib—PSMB9—Betamethasone—Budesonide—asthma	0.000316	0.0285	CbGdCrCtD
Carfilzomib—PSMB9—Dexamethasone—Budesonide—asthma	0.000316	0.0285	CbGdCrCtD
Carfilzomib—Diarrhoea—Loratadine—asthma	0.000316	0.00103	CcSEcCtD
Carfilzomib—Fatigue—Montelukast—asthma	0.000314	0.00103	CcSEcCtD
Carfilzomib—Body temperature increased—Mometasone—asthma	0.000313	0.00102	CcSEcCtD
Carfilzomib—Dyspnoea—Salbutamol—asthma	0.000313	0.00102	CcSEcCtD
Carfilzomib—PSMB9—Dexamethasone—Flunisolide—asthma	0.000312	0.0282	CbGdCrCtD
Carfilzomib—PSMB9—Betamethasone—Flunisolide—asthma	0.000312	0.0282	CbGdCrCtD
Carfilzomib—Pain—Montelukast—asthma	0.000311	0.00102	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Prednisolone—asthma	0.000311	0.00102	CcSEcCtD
Carfilzomib—Hypokalaemia—Betamethasone—asthma	0.000311	0.00102	CcSEcCtD
Carfilzomib—Hypokalaemia—Dexamethasone—asthma	0.000311	0.00102	CcSEcCtD
Carfilzomib—Vomiting—Aminophylline—asthma	0.00031	0.00102	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Budesonide—asthma	0.00031	0.00101	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Prednisolone—asthma	0.000309	0.00101	CcSEcCtD
Carfilzomib—Insomnia—Budesonide—asthma	0.000307	0.00101	CcSEcCtD
Carfilzomib—Asthenia—Flunisolide—asthma	0.000306	0.001	CcSEcCtD
Carfilzomib—Nausea—Fluticasone Propionate—asthma	0.000306	0.001	CcSEcCtD
Carfilzomib—Headache—Aminophylline—asthma	0.000306	0.001	CcSEcCtD
Carfilzomib—Nausea—Salmeterol—asthma	0.000305	0.001	CcSEcCtD
Carfilzomib—Dizziness—Loratadine—asthma	0.000305	0.000999	CcSEcCtD
Carfilzomib—Decreased appetite—Salbutamol—asthma	0.000305	0.000999	CcSEcCtD
Carfilzomib—Dizziness—Tiotropium—asthma	0.000304	0.000997	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Hydrocortisone—asthma	0.000304	0.000995	CcSEcCtD
Carfilzomib—Dyspnoea—Budesonide—asthma	0.000303	0.000992	CcSEcCtD
Carfilzomib—Fatigue—Salbutamol—asthma	0.000302	0.000991	CcSEcCtD
Carfilzomib—Upper respiratory tract infection—Triamcinolone—asthma	0.000302	0.000991	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Hydrocortisone—asthma	0.000302	0.000989	CcSEcCtD
Carfilzomib—Constipation—Salbutamol—asthma	0.0003	0.000983	CcSEcCtD
Carfilzomib—Pain—Salbutamol—asthma	0.0003	0.000983	CcSEcCtD
Carfilzomib—Decreased appetite—Budesonide—asthma	0.000295	0.000968	CcSEcCtD
Carfilzomib—Body temperature increased—Arformoterol—asthma	0.000294	0.000962	CcSEcCtD
Carfilzomib—Body temperature increased—Formoterol—asthma	0.000294	0.000962	CcSEcCtD
Carfilzomib—Vomiting—Loratadine—asthma	0.000293	0.00096	CcSEcCtD
Carfilzomib—Fatigue—Budesonide—asthma	0.000293	0.00096	CcSEcCtD
Carfilzomib—Vomiting—Tiotropium—asthma	0.000293	0.000959	CcSEcCtD
Carfilzomib—Diarrhoea—Flunisolide—asthma	0.000292	0.000956	CcSEcCtD
Carfilzomib—Constipation—Budesonide—asthma	0.000291	0.000952	CcSEcCtD
Carfilzomib—Pain—Budesonide—asthma	0.000291	0.000952	CcSEcCtD
Carfilzomib—Nausea—Aminophylline—asthma	0.00029	0.00095	CcSEcCtD
Carfilzomib—Headache—Loratadine—asthma	0.000289	0.000946	CcSEcCtD
Carfilzomib—Headache—Tiotropium—asthma	0.000288	0.000945	CcSEcCtD
Carfilzomib—Body temperature increased—Montelukast—asthma	0.000288	0.000942	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Triamcinolone—asthma	0.000286	0.000937	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Methylprednisolone—asthma	0.000285	0.000935	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Triamcinolone—asthma	0.000284	0.000931	CcSEcCtD
Carfilzomib—Asthenia—Mometasone—asthma	0.000284	0.00093	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Methylprednisolone—asthma	0.000284	0.000929	CcSEcCtD
Carfilzomib—Cardiac arrest—Prednisone—asthma	0.000283	0.000927	CcSEcCtD
Carfilzomib—Dizziness—Flunisolide—asthma	0.000282	0.000924	CcSEcCtD
Carfilzomib—Body temperature increased—Salbutamol—asthma	0.000277	0.000908	CcSEcCtD
Carfilzomib—Nausea—Loratadine—asthma	0.000274	0.000897	CcSEcCtD
Carfilzomib—Nausea—Tiotropium—asthma	0.000273	0.000896	CcSEcCtD
Carfilzomib—PSMB8—Fluorometholone—Fluticasone furoate—asthma	0.000272	0.0246	CbGdCrCtD
Carfilzomib—Vomiting—Flunisolide—asthma	0.000271	0.000889	CcSEcCtD
Carfilzomib—Diarrhoea—Mometasone—asthma	0.000271	0.000887	CcSEcCtD
Carfilzomib—Hypokalaemia—Prednisone—asthma	0.000271	0.000887	CcSEcCtD
Carfilzomib—Body temperature increased—Budesonide—asthma	0.000269	0.00088	CcSEcCtD
Carfilzomib—Headache—Flunisolide—asthma	0.000267	0.000876	CcSEcCtD
Carfilzomib—Asthenia—Formoterol—asthma	0.000267	0.000873	CcSEcCtD
Carfilzomib—Asthenia—Arformoterol—asthma	0.000267	0.000873	CcSEcCtD
Carfilzomib—Hyperglycaemia—Betamethasone—asthma	0.000266	0.000872	CcSEcCtD
Carfilzomib—Hyperglycaemia—Dexamethasone—asthma	0.000266	0.000872	CcSEcCtD
Carfilzomib—Asthenia—Montelukast—asthma	0.000261	0.000855	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Betamethasone—asthma	0.00026	0.00085	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Dexamethasone—asthma	0.00026	0.00085	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Betamethasone—asthma	0.000258	0.000845	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Dexamethasone—asthma	0.000258	0.000845	CcSEcCtD
Carfilzomib—PSMB9—Betamethasone—Mometasone—asthma	0.000256	0.0231	CbGdCrCtD
Carfilzomib—PSMB9—Dexamethasone—Mometasone—asthma	0.000256	0.0231	CbGdCrCtD
Carfilzomib—Diarrhoea—Arformoterol—asthma	0.000254	0.000833	CcSEcCtD
Carfilzomib—Diarrhoea—Formoterol—asthma	0.000254	0.000833	CcSEcCtD
Carfilzomib—PSMB8—Fluorometholone—Fluticasone Propionate—asthma	0.000254	0.0229	CbGdCrCtD
Carfilzomib—Nausea—Flunisolide—asthma	0.000253	0.00083	CcSEcCtD
Carfilzomib—Asthenia—Salbutamol—asthma	0.000252	0.000824	CcSEcCtD
Carfilzomib—Vomiting—Mometasone—asthma	0.000252	0.000824	CcSEcCtD
Carfilzomib—Diarrhoea—Montelukast—asthma	0.000249	0.000816	CcSEcCtD
Carfilzomib—Headache—Mometasone—asthma	0.000248	0.000812	CcSEcCtD
Carfilzomib—Dizziness—Formoterol—asthma	0.000246	0.000805	CcSEcCtD
Carfilzomib—Dizziness—Arformoterol—asthma	0.000246	0.000805	CcSEcCtD
Carfilzomib—Asthenia—Budesonide—asthma	0.000244	0.000799	CcSEcCtD
Carfilzomib—Cardiac disorder—Methylprednisolone—asthma	0.000241	0.00079	CcSEcCtD
Carfilzomib—Dizziness—Montelukast—asthma	0.000241	0.000788	CcSEcCtD
Carfilzomib—Neutropenia—Prednisone—asthma	0.00024	0.000787	CcSEcCtD
Carfilzomib—Diarrhoea—Salbutamol—asthma	0.00024	0.000786	CcSEcCtD
Carfilzomib—Vomiting—Formoterol—asthma	0.000236	0.000774	CcSEcCtD
Carfilzomib—Vomiting—Arformoterol—asthma	0.000236	0.000774	CcSEcCtD
Carfilzomib—Nausea—Mometasone—asthma	0.000235	0.00077	CcSEcCtD
Carfilzomib—Headache—Arformoterol—asthma	0.000233	0.000762	CcSEcCtD
Carfilzomib—Headache—Formoterol—asthma	0.000233	0.000762	CcSEcCtD
Carfilzomib—Diarrhoea—Budesonide—asthma	0.000233	0.000762	CcSEcCtD
Carfilzomib—Dizziness—Salbutamol—asthma	0.000232	0.00076	CcSEcCtD
Carfilzomib—Hyperglycaemia—Prednisone—asthma	0.000232	0.00076	CcSEcCtD
Carfilzomib—Vomiting—Montelukast—asthma	0.000231	0.000758	CcSEcCtD
Carfilzomib—Headache—Montelukast—asthma	0.000228	0.000747	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Prednisone—asthma	0.000226	0.00074	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Prednisone—asthma	0.000225	0.000736	CcSEcCtD
Carfilzomib—Dizziness—Budesonide—asthma	0.000225	0.000736	CcSEcCtD
Carfilzomib—Vomiting—Salbutamol—asthma	0.000223	0.000731	CcSEcCtD
Carfilzomib—Nausea—Arformoterol—asthma	0.000221	0.000723	CcSEcCtD
Carfilzomib—Nausea—Formoterol—asthma	0.000221	0.000723	CcSEcCtD
Carfilzomib—Headache—Salbutamol—asthma	0.00022	0.00072	CcSEcCtD
Carfilzomib—Back pain—Triamcinolone—asthma	0.000219	0.000718	CcSEcCtD
Carfilzomib—Nausea—Montelukast—asthma	0.000216	0.000708	CcSEcCtD
Carfilzomib—Vomiting—Budesonide—asthma	0.000216	0.000708	CcSEcCtD
Carfilzomib—Headache—Budesonide—asthma	0.000213	0.000697	CcSEcCtD
Carfilzomib—Hypertension—Prednisolone—asthma	0.000213	0.000697	CcSEcCtD
Carfilzomib—Nausea—Salbutamol—asthma	0.000208	0.000683	CcSEcCtD
Carfilzomib—Hypertension—Hydrocortisone—asthma	0.000208	0.000681	CcSEcCtD
Carfilzomib—PSMB8—Diflorasone—Fluticasone furoate—asthma	0.000207	0.0187	CbGdCrCtD
Carfilzomib—Nausea—Budesonide—asthma	0.000202	0.000661	CcSEcCtD
Carfilzomib—Cough—Triamcinolone—asthma	0.000198	0.000648	CcSEcCtD
Carfilzomib—Hypertension—Triamcinolone—asthma	0.000196	0.000641	CcSEcCtD
Carfilzomib—Hypertension—Methylprednisolone—asthma	0.000195	0.00064	CcSEcCtD
Carfilzomib—Infection—Hydrocortisone—asthma	0.000195	0.000639	CcSEcCtD
Carfilzomib—PSMB8—Diflorasone—Fluticasone Propionate—asthma	0.000193	0.0174	CbGdCrCtD
Carfilzomib—Arthralgia—Methylprednisolone—asthma	0.000193	0.000631	CcSEcCtD
Carfilzomib—Anorexia—Hydrocortisone—asthma	0.000187	0.000614	CcSEcCtD
Carfilzomib—PSMB8—Fluorometholone—Beclomethasone—asthma	0.000186	0.0168	CbGdCrCtD
Carfilzomib—Infection—Triamcinolone—asthma	0.000184	0.000602	CcSEcCtD
Carfilzomib—Infection—Methylprednisolone—asthma	0.000183	0.000601	CcSEcCtD
Carfilzomib—Insomnia—Prednisolone—asthma	0.000182	0.000596	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Hydrocortisone—asthma	0.000179	0.000586	CcSEcCtD
Carfilzomib—PSMB8—Fluorometholone—Budesonide—asthma	0.000179	0.0161	CbGdCrCtD
Carfilzomib—Insomnia—Hydrocortisone—asthma	0.000178	0.000582	CcSEcCtD
Carfilzomib—Hypertension—Dexamethasone—asthma	0.000178	0.000582	CcSEcCtD
Carfilzomib—Hypertension—Betamethasone—asthma	0.000178	0.000582	CcSEcCtD
Carfilzomib—PSMB8—Fluorometholone—Flunisolide—asthma	0.000176	0.0159	CbGdCrCtD
Carfilzomib—Pain—Prednisolone—asthma	0.000172	0.000564	CcSEcCtD
Carfilzomib—Decreased appetite—Hydrocortisone—asthma	0.000171	0.00056	CcSEcCtD
Carfilzomib—Fatigue—Hydrocortisone—asthma	0.000169	0.000555	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Triamcinolone—asthma	0.000169	0.000552	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Methylprednisolone—asthma	0.000168	0.000551	CcSEcCtD
Carfilzomib—Pain—Hydrocortisone—asthma	0.000168	0.00055	CcSEcCtD
Carfilzomib—Insomnia—Triamcinolone—asthma	0.000167	0.000548	CcSEcCtD
Carfilzomib—Insomnia—Methylprednisolone—asthma	0.000167	0.000547	CcSEcCtD
Carfilzomib—Infection—Dexamethasone—asthma	0.000167	0.000546	CcSEcCtD
Carfilzomib—Infection—Betamethasone—asthma	0.000167	0.000546	CcSEcCtD
Carfilzomib—Anaemia—Prednisone—asthma	0.000166	0.000542	CcSEcCtD
Carfilzomib—Dyspnoea—Triamcinolone—asthma	0.000165	0.00054	CcSEcCtD
Carfilzomib—Thrombocytopenia—Dexamethasone—asthma	0.000164	0.000538	CcSEcCtD
Carfilzomib—Thrombocytopenia—Betamethasone—asthma	0.000164	0.000538	CcSEcCtD
Carfilzomib—PSMB9—Betamethasone—Hydrocortisone—asthma	0.000162	0.0146	CbGdCrCtD
Carfilzomib—PSMB9—Dexamethasone—Hydrocortisone—asthma	0.000162	0.0146	CbGdCrCtD
Carfilzomib—Anorexia—Dexamethasone—asthma	0.00016	0.000524	CcSEcCtD
Carfilzomib—Anorexia—Betamethasone—asthma	0.00016	0.000524	CcSEcCtD
Carfilzomib—Fatigue—Triamcinolone—asthma	0.00016	0.000523	CcSEcCtD
Carfilzomib—Fatigue—Methylprednisolone—asthma	0.000159	0.000521	CcSEcCtD
Carfilzomib—Pain—Triamcinolone—asthma	0.000158	0.000518	CcSEcCtD
Carfilzomib—Body temperature increased—Hydrocortisone—asthma	0.000155	0.000509	CcSEcCtD
Carfilzomib—Hypertension—Prednisone—asthma	0.000155	0.000507	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Betamethasone—asthma	0.000153	0.000501	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Dexamethasone—asthma	0.000153	0.000501	CcSEcCtD
Carfilzomib—PSMB9—Betamethasone—Methylprednisolone—asthma	0.000153	0.0138	CbGdCrCtD
Carfilzomib—PSMB9—Dexamethasone—Methylprednisolone—asthma	0.000153	0.0138	CbGdCrCtD
Carfilzomib—Arthralgia—Prednisone—asthma	0.000153	0.0005	CcSEcCtD
Carfilzomib—Insomnia—Betamethasone—asthma	0.000152	0.000497	CcSEcCtD
Carfilzomib—Insomnia—Dexamethasone—asthma	0.000152	0.000497	CcSEcCtD
Carfilzomib—PSMB9—Dexamethasone—Betamethasone—asthma	0.00015	0.0136	CbGdCrCtD
Carfilzomib—PSMB9—Betamethasone—Dexamethasone—asthma	0.00015	0.0136	CbGdCrCtD
Carfilzomib—PSMB9—Betamethasone—Triamcinolone—asthma	0.000147	0.0133	CbGdCrCtD
Carfilzomib—PSMB9—Dexamethasone—Triamcinolone—asthma	0.000147	0.0133	CbGdCrCtD
Carfilzomib—Body temperature increased—Triamcinolone—asthma	0.000146	0.000479	CcSEcCtD
Carfilzomib—Decreased appetite—Dexamethasone—asthma	0.000146	0.000478	CcSEcCtD
Carfilzomib—Decreased appetite—Betamethasone—asthma	0.000146	0.000478	CcSEcCtD
Carfilzomib—Infection—Prednisone—asthma	0.000145	0.000476	CcSEcCtD
Carfilzomib—Fatigue—Dexamethasone—asthma	0.000145	0.000474	CcSEcCtD
Carfilzomib—Fatigue—Betamethasone—asthma	0.000145	0.000474	CcSEcCtD
Carfilzomib—PSMB8—Fluorometholone—Mometasone—asthma	0.000145	0.0131	CbGdCrCtD
Carfilzomib—Pain—Betamethasone—asthma	0.000144	0.00047	CcSEcCtD
Carfilzomib—Pain—Dexamethasone—asthma	0.000144	0.00047	CcSEcCtD
Carfilzomib—PSMB8—Diflorasone—Beclomethasone—asthma	0.000142	0.0128	CbGdCrCtD
Carfilzomib—Asthenia—Hydrocortisone—asthma	0.000141	0.000462	CcSEcCtD
Carfilzomib—Anorexia—Prednisone—asthma	0.000139	0.000456	CcSEcCtD
Carfilzomib—PSMB9—Dexamethasone—Prednisone—asthma	0.000139	0.0126	CbGdCrCtD
Carfilzomib—PSMB9—Betamethasone—Prednisone—asthma	0.000139	0.0126	CbGdCrCtD
Carfilzomib—PSMB8—Diflorasone—Budesonide—asthma	0.000136	0.0123	CbGdCrCtD
Carfilzomib—PSMB9—Betamethasone—Prednisolone—asthma	0.000136	0.0123	CbGdCrCtD
Carfilzomib—PSMB9—Dexamethasone—Prednisolone—asthma	0.000136	0.0123	CbGdCrCtD
Carfilzomib—Diarrhoea—Hydrocortisone—asthma	0.000134	0.00044	CcSEcCtD
Carfilzomib—PSMB8—Diflorasone—Flunisolide—asthma	0.000134	0.0121	CbGdCrCtD
Carfilzomib—Musculoskeletal discomfort—Prednisone—asthma	0.000133	0.000436	CcSEcCtD
Carfilzomib—Dizziness—Prednisolone—asthma	0.000133	0.000436	CcSEcCtD
Carfilzomib—Asthenia—Triamcinolone—asthma	0.000133	0.000435	CcSEcCtD
Carfilzomib—Body temperature increased—Betamethasone—asthma	0.000133	0.000435	CcSEcCtD
Carfilzomib—Body temperature increased—Dexamethasone—asthma	0.000133	0.000435	CcSEcCtD
Carfilzomib—Asthenia—Methylprednisolone—asthma	0.000132	0.000434	CcSEcCtD
Carfilzomib—Insomnia—Prednisone—asthma	0.000132	0.000433	CcSEcCtD
Carfilzomib—Dizziness—Hydrocortisone—asthma	0.00013	0.000426	CcSEcCtD
Carfilzomib—Decreased appetite—Prednisone—asthma	0.000127	0.000416	CcSEcCtD
Carfilzomib—PSMB8—Medrysone—Hydrocortisone—asthma	0.000126	0.0114	CbGdCrCtD
Carfilzomib—Diarrhoea—Methylprednisolone—asthma	0.000126	0.000414	CcSEcCtD
Carfilzomib—Fatigue—Prednisone—asthma	0.000126	0.000413	CcSEcCtD
Carfilzomib—Headache—Prednisolone—asthma	0.000126	0.000413	CcSEcCtD
Carfilzomib—Constipation—Prednisone—asthma	0.000125	0.00041	CcSEcCtD
Carfilzomib—Vomiting—Hydrocortisone—asthma	0.000125	0.000409	CcSEcCtD
Carfilzomib—Headache—Hydrocortisone—asthma	0.000123	0.000403	CcSEcCtD
Carfilzomib—Dizziness—Triamcinolone—asthma	0.000122	0.000401	CcSEcCtD
Carfilzomib—Dizziness—Methylprednisolone—asthma	0.000122	0.0004	CcSEcCtD
Carfilzomib—Asthenia—Betamethasone—asthma	0.00012	0.000395	CcSEcCtD
Carfilzomib—Asthenia—Dexamethasone—asthma	0.00012	0.000395	CcSEcCtD
Carfilzomib—Nausea—Prednisolone—asthma	0.00012	0.000391	CcSEcCtD
Carfilzomib—PSMB8—Medrysone—Methylprednisolone—asthma	0.000119	0.0108	CbGdCrCtD
Carfilzomib—Vomiting—Triamcinolone—asthma	0.000118	0.000385	CcSEcCtD
Carfilzomib—Vomiting—Methylprednisolone—asthma	0.000117	0.000384	CcSEcCtD
Carfilzomib—Nausea—Hydrocortisone—asthma	0.000117	0.000382	CcSEcCtD
Carfilzomib—Headache—Triamcinolone—asthma	0.000116	0.00038	CcSEcCtD
Carfilzomib—Headache—Methylprednisolone—asthma	0.000116	0.000379	CcSEcCtD
Carfilzomib—Body temperature increased—Prednisone—asthma	0.000116	0.000379	CcSEcCtD
Carfilzomib—Diarrhoea—Dexamethasone—asthma	0.000115	0.000376	CcSEcCtD
Carfilzomib—Diarrhoea—Betamethasone—asthma	0.000115	0.000376	CcSEcCtD
Carfilzomib—PSMB8—Dexamethasone—Fluticasone furoate—asthma	0.000111	0.01	CbGdCrCtD
Carfilzomib—PSMB8—Betamethasone—Fluticasone furoate—asthma	0.000111	0.01	CbGdCrCtD
Carfilzomib—Dizziness—Dexamethasone—asthma	0.000111	0.000364	CcSEcCtD
Carfilzomib—Dizziness—Betamethasone—asthma	0.000111	0.000364	CcSEcCtD
Carfilzomib—PSMB8—Diflorasone—Mometasone—asthma	0.00011	0.00994	CbGdCrCtD
Carfilzomib—Nausea—Triamcinolone—asthma	0.00011	0.00036	CcSEcCtD
Carfilzomib—Nausea—Methylprednisolone—asthma	0.00011	0.000359	CcSEcCtD
Carfilzomib—Vomiting—Betamethasone—asthma	0.000107	0.00035	CcSEcCtD
Carfilzomib—Vomiting—Dexamethasone—asthma	0.000107	0.00035	CcSEcCtD
Carfilzomib—PSMB8—Medrysone—Prednisolone—asthma	0.000106	0.00959	CbGdCrCtD
Carfilzomib—Headache—Betamethasone—asthma	0.000105	0.000344	CcSEcCtD
Carfilzomib—Headache—Dexamethasone—asthma	0.000105	0.000344	CcSEcCtD
Carfilzomib—Asthenia—Prednisone—asthma	0.000105	0.000344	CcSEcCtD
Carfilzomib—PSMB8—Dexamethasone—Fluticasone Propionate—asthma	0.000104	0.00936	CbGdCrCtD
Carfilzomib—PSMB8—Betamethasone—Fluticasone Propionate—asthma	0.000104	0.00936	CbGdCrCtD
Carfilzomib—Diarrhoea—Prednisone—asthma	0.0001	0.000328	CcSEcCtD
Carfilzomib—Nausea—Betamethasone—asthma	9.97e-05	0.000327	CcSEcCtD
Carfilzomib—Nausea—Dexamethasone—asthma	9.97e-05	0.000327	CcSEcCtD
Carfilzomib—Dizziness—Prednisone—asthma	9.67e-05	0.000317	CcSEcCtD
Carfilzomib—Vomiting—Prednisone—asthma	9.3e-05	0.000304	CcSEcCtD
Carfilzomib—Headache—Prednisone—asthma	9.16e-05	0.0003	CcSEcCtD
Carfilzomib—PSMB8—Fluorometholone—Hydrocortisone—asthma	9.15e-05	0.00826	CbGdCrCtD
Carfilzomib—Nausea—Prednisone—asthma	8.69e-05	0.000284	CcSEcCtD
Carfilzomib—PSMB8—Fluorometholone—Methylprednisolone—asthma	8.64e-05	0.0078	CbGdCrCtD
Carfilzomib—PSMB8—Fluorometholone—Betamethasone—asthma	8.5e-05	0.00767	CbGdCrCtD
Carfilzomib—PSMB8—Fluorometholone—Dexamethasone—asthma	8.5e-05	0.00767	CbGdCrCtD
Carfilzomib—PSMB8—Fluorometholone—Triamcinolone—asthma	8.3e-05	0.0075	CbGdCrCtD
Carfilzomib—PSMB8—Fluorometholone—Prednisone—asthma	7.88e-05	0.00711	CbGdCrCtD
Carfilzomib—PSMB8—Fluorometholone—Prednisolone—asthma	7.69e-05	0.00694	CbGdCrCtD
Carfilzomib—PSMB8—Betamethasone—Beclomethasone—asthma	7.62e-05	0.00688	CbGdCrCtD
Carfilzomib—PSMB8—Dexamethasone—Beclomethasone—asthma	7.62e-05	0.00688	CbGdCrCtD
Carfilzomib—PSMB8—Dexamethasone—Budesonide—asthma	7.3e-05	0.00659	CbGdCrCtD
Carfilzomib—PSMB8—Betamethasone—Budesonide—asthma	7.3e-05	0.00659	CbGdCrCtD
Carfilzomib—PSMB8—Dexamethasone—Flunisolide—asthma	7.21e-05	0.00651	CbGdCrCtD
Carfilzomib—PSMB8—Betamethasone—Flunisolide—asthma	7.21e-05	0.00651	CbGdCrCtD
Carfilzomib—PSMB8—Testosterone Propionate—Hydrocortisone—asthma	7.04e-05	0.00636	CbGdCrCtD
Carfilzomib—PSMB8—Diflorasone—Methylprednisolone—asthma	6.58e-05	0.00594	CbGdCrCtD
Carfilzomib—PSMB8—Diflorasone—Dexamethasone—asthma	6.47e-05	0.00584	CbGdCrCtD
Carfilzomib—PSMB8—Diflorasone—Betamethasone—asthma	6.47e-05	0.00584	CbGdCrCtD
Carfilzomib—PSMB8—Diflorasone—Triamcinolone—asthma	6.32e-05	0.00571	CbGdCrCtD
Carfilzomib—PSMB8—Diflorasone—Prednisone—asthma	6e-05	0.00542	CbGdCrCtD
Carfilzomib—PSMB8—Betamethasone—Mometasone—asthma	5.91e-05	0.00533	CbGdCrCtD
Carfilzomib—PSMB8—Dexamethasone—Mometasone—asthma	5.91e-05	0.00533	CbGdCrCtD
Carfilzomib—PSMB8—Diflorasone—Prednisolone—asthma	5.86e-05	0.00529	CbGdCrCtD
Carfilzomib—PSMB8—Norethindrone—Hydrocortisone—asthma	5.28e-05	0.00476	CbGdCrCtD
Carfilzomib—PSMB8—Levonorgestrel—Hydrocortisone—asthma	4.2e-05	0.00379	CbGdCrCtD
Carfilzomib—PSMB8—Dexamethasone—Hydrocortisone—asthma	3.74e-05	0.00337	CbGdCrCtD
Carfilzomib—PSMB8—Betamethasone—Hydrocortisone—asthma	3.74e-05	0.00337	CbGdCrCtD
Carfilzomib—PSMB8—Betamethasone—Methylprednisolone—asthma	3.53e-05	0.00318	CbGdCrCtD
Carfilzomib—PSMB8—Dexamethasone—Methylprednisolone—asthma	3.53e-05	0.00318	CbGdCrCtD
Carfilzomib—PSMB8—Dexamethasone—Betamethasone—asthma	3.47e-05	0.00313	CbGdCrCtD
Carfilzomib—PSMB8—Betamethasone—Dexamethasone—asthma	3.47e-05	0.00313	CbGdCrCtD
Carfilzomib—PSMB8—Betamethasone—Triamcinolone—asthma	3.39e-05	0.00306	CbGdCrCtD
Carfilzomib—PSMB8—Dexamethasone—Triamcinolone—asthma	3.39e-05	0.00306	CbGdCrCtD
Carfilzomib—PSMB8—Dexamethasone—Prednisone—asthma	3.22e-05	0.00291	CbGdCrCtD
Carfilzomib—PSMB8—Betamethasone—Prednisone—asthma	3.22e-05	0.00291	CbGdCrCtD
Carfilzomib—PSMB8—Betamethasone—Prednisolone—asthma	3.14e-05	0.00284	CbGdCrCtD
Carfilzomib—PSMB8—Dexamethasone—Prednisolone—asthma	3.14e-05	0.00284	CbGdCrCtD
Carfilzomib—PSMB10—Signaling Pathways—CCL2—asthma	2.73e-05	0.000117	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—IL6R—asthma	2.72e-05	0.000116	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IFNG—asthma	2.72e-05	0.000116	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IFNG—asthma	2.72e-05	0.000116	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IFNG—asthma	2.72e-05	0.000116	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—SERPINE1—asthma	2.71e-05	0.000116	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CCL2—asthma	2.71e-05	0.000116	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—PPP2CA—asthma	2.71e-05	0.000116	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—IL6R—asthma	2.7e-05	0.000116	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—BCL2—asthma	2.7e-05	0.000116	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CCR5—asthma	2.7e-05	0.000116	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CCR5—asthma	2.7e-05	0.000116	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CCR5—asthma	2.7e-05	0.000116	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ARG2—asthma	2.69e-05	0.000115	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—STAT3—asthma	2.68e-05	0.000115	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IFNG—asthma	2.68e-05	0.000115	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—STAT3—asthma	2.67e-05	0.000114	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CCR5—asthma	2.66e-05	0.000114	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—IL2RA—asthma	2.66e-05	0.000114	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IL2RA—asthma	2.66e-05	0.000114	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IL2RA—asthma	2.66e-05	0.000114	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—PTGS2—asthma	2.66e-05	0.000114	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—RHOA—asthma	2.66e-05	0.000114	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—RHOA—asthma	2.66e-05	0.000114	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—RHOA—asthma	2.66e-05	0.000114	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—PTGS2—asthma	2.64e-05	0.000113	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—C3—asthma	2.64e-05	0.000113	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—C3—asthma	2.64e-05	0.000113	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—C3—asthma	2.64e-05	0.000113	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—NOS3—asthma	2.63e-05	0.000113	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—NOS3—asthma	2.63e-05	0.000113	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—NOS3—asthma	2.63e-05	0.000113	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IL2RA—asthma	2.62e-05	0.000112	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CD4—asthma	2.62e-05	0.000112	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CD4—asthma	2.62e-05	0.000112	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CD4—asthma	2.62e-05	0.000112	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—RHOA—asthma	2.62e-05	0.000112	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—C3—asthma	2.6e-05	0.000111	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—NOS3—asthma	2.59e-05	0.000111	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CD4—asthma	2.59e-05	0.000111	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—PDGFB—asthma	2.57e-05	0.00011	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—PDGFB—asthma	2.57e-05	0.00011	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—PDGFB—asthma	2.57e-05	0.00011	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—SERPINE1—asthma	2.54e-05	0.000109	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—PDGFB—asthma	2.53e-05	0.000108	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—SERPINE1—asthma	2.53e-05	0.000108	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—POMC—asthma	2.52e-05	0.000108	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—POMC—asthma	2.52e-05	0.000108	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—POMC—asthma	2.52e-05	0.000108	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—asthma	2.51e-05	0.000107	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—POMC—asthma	2.49e-05	0.000107	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—STAT3—asthma	2.47e-05	0.000106	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—STAT3—asthma	2.46e-05	0.000105	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—LEP—asthma	2.46e-05	0.000105	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—LEP—asthma	2.46e-05	0.000105	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—LEP—asthma	2.46e-05	0.000105	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—RHOA—asthma	2.45e-05	0.000105	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—RHOA—asthma	2.44e-05	0.000105	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—EGFR—asthma	2.44e-05	0.000104	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—NOS3—asthma	2.43e-05	0.000104	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—EGFR—asthma	2.42e-05	0.000104	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IL1B—asthma	2.42e-05	0.000104	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IL1B—asthma	2.42e-05	0.000104	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IL1B—asthma	2.42e-05	0.000104	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—LEP—asthma	2.42e-05	0.000104	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—CD4—asthma	2.42e-05	0.000104	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—CD4—asthma	2.42e-05	0.000104	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—CD4—asthma	2.42e-05	0.000104	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—NOS3—asthma	2.42e-05	0.000104	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IL2—asthma	2.41e-05	0.000103	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IL2—asthma	2.41e-05	0.000103	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IL2—asthma	2.41e-05	0.000103	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—HMOX1—asthma	2.41e-05	0.000103	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—PTGS2—asthma	2.4e-05	0.000103	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—PTGS2—asthma	2.4e-05	0.000103	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—PTGS2—asthma	2.4e-05	0.000103	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IL1B—asthma	2.39e-05	0.000102	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—CD4—asthma	2.39e-05	0.000102	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IL2—asthma	2.38e-05	0.000102	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—PTGS2—asthma	2.37e-05	0.000102	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—FN1—asthma	2.32e-05	9.93e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—FN1—asthma	2.32e-05	9.93e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—FN1—asthma	2.32e-05	9.93e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—PTEN—asthma	2.32e-05	9.93e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—PTEN—asthma	2.31e-05	9.88e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—asthma	2.3e-05	9.86e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—ALB—asthma	2.3e-05	9.86e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—ALB—asthma	2.3e-05	9.86e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—ALB—asthma	2.3e-05	9.86e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—TGFB1—asthma	2.29e-05	9.82e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—FN1—asthma	2.28e-05	9.79e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—TGFB1—asthma	2.28e-05	9.78e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—PTEN—asthma	2.27e-05	9.73e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—PTEN—asthma	2.27e-05	9.73e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—PTEN—asthma	2.27e-05	9.73e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—ALB—asthma	2.27e-05	9.72e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—asthma	2.26e-05	9.67e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—EGFR—asthma	2.25e-05	9.63e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—PTEN—asthma	2.24e-05	9.59e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—EGFR—asthma	2.24e-05	9.59e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ALOX15—asthma	2.23e-05	9.55e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ALOX5AP—asthma	2.23e-05	9.55e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—NOS3—asthma	2.2e-05	9.43e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—NOS3—asthma	2.2e-05	9.43e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—NOS3—asthma	2.2e-05	9.43e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—NOS3—asthma	2.17e-05	9.3e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CXCL8—asthma	2.15e-05	9.23e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—asthma	2.15e-05	9.21e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CXCL8—asthma	2.14e-05	9.19e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CHAT—asthma	2.13e-05	9.11e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—POMC—asthma	2.11e-05	9.04e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—POMC—asthma	2.11e-05	9.04e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—POMC—asthma	2.11e-05	9.04e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—PTEN—asthma	2.1e-05	8.98e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—PTEN—asthma	2.1e-05	8.98e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—PTEN—asthma	2.1e-05	8.98e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—POMC—asthma	2.08e-05	8.91e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—PTEN—asthma	2.07e-05	8.86e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CCL2—asthma	2.07e-05	8.85e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CCL2—asthma	2.07e-05	8.85e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CCL2—asthma	2.07e-05	8.85e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IL6R—asthma	2.06e-05	8.82e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IL6R—asthma	2.06e-05	8.82e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—IL6R—asthma	2.06e-05	8.82e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—IL2—asthma	2.06e-05	8.82e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—IL2—asthma	2.05e-05	8.78e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CCL2—asthma	2.04e-05	8.72e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—STAT3—asthma	2.03e-05	8.7e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—STAT3—asthma	2.03e-05	8.7e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—STAT3—asthma	2.03e-05	8.7e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IL6R—asthma	2.03e-05	8.7e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—PTGS2—asthma	2.01e-05	8.63e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—PTGS2—asthma	2.01e-05	8.63e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—PTGS2—asthma	2.01e-05	8.63e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—STAT3—asthma	2e-05	8.58e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—PTGS2—asthma	1.99e-05	8.5e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—MMP9—asthma	1.95e-05	8.35e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—MMP9—asthma	1.94e-05	8.31e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—PTEN—asthma	1.94e-05	8.3e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—PTEN—asthma	1.93e-05	8.26e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—SERPINE1—asthma	1.93e-05	8.26e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—SERPINE1—asthma	1.93e-05	8.26e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—SERPINE1—asthma	1.93e-05	8.26e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—SERPINE1—asthma	1.9e-05	8.14e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ALOX5—asthma	1.9e-05	8.12e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—STAT3—asthma	1.88e-05	8.03e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—STAT3—asthma	1.88e-05	8.03e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—STAT3—asthma	1.88e-05	8.03e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—IL6—asthma	1.87e-05	8.02e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—IL6—asthma	1.86e-05	7.98e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—RHOA—asthma	1.86e-05	7.97e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—RHOA—asthma	1.86e-05	7.97e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—RHOA—asthma	1.86e-05	7.97e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—STAT3—asthma	1.85e-05	7.92e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—EGFR—asthma	1.85e-05	7.91e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—EGFR—asthma	1.85e-05	7.91e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—EGFR—asthma	1.85e-05	7.91e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—NOS3—asthma	1.84e-05	7.89e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—NOS3—asthma	1.84e-05	7.89e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—NOS3—asthma	1.84e-05	7.89e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—RHOA—asthma	1.83e-05	7.86e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—EGFR—asthma	1.82e-05	7.8e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—NOS3—asthma	1.82e-05	7.77e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CARM1—asthma	1.81e-05	7.75e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—DCN—asthma	1.78e-05	7.64e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—PTEN—asthma	1.76e-05	7.52e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—PTEN—asthma	1.76e-05	7.52e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—PTEN—asthma	1.76e-05	7.52e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—VEGFA—asthma	1.75e-05	7.5e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—VEGFA—asthma	1.74e-05	7.46e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—TGFB1—asthma	1.74e-05	7.45e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—TGFB1—asthma	1.74e-05	7.45e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—TGFB1—asthma	1.74e-05	7.45e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ALDH2—asthma	1.73e-05	7.43e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—STAT3—asthma	1.73e-05	7.42e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—PTEN—asthma	1.73e-05	7.42e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—IL6—asthma	1.73e-05	7.4e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—STAT3—asthma	1.72e-05	7.39e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—IL6—asthma	1.72e-05	7.37e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—TGFB1—asthma	1.71e-05	7.34e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—EGFR—asthma	1.7e-05	7.3e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—EGFR—asthma	1.7e-05	7.3e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—EGFR—asthma	1.7e-05	7.3e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—EGFR—asthma	1.68e-05	7.2e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GSTT1—asthma	1.65e-05	7.07e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CXCL8—asthma	1.63e-05	6.99e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CXCL8—asthma	1.63e-05	6.99e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CXCL8—asthma	1.63e-05	6.99e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CXCL8—asthma	1.61e-05	6.9e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—TGFB1—asthma	1.61e-05	6.88e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—TGFB1—asthma	1.6e-05	6.85e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—EGFR—asthma	1.58e-05	6.75e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—EGFR—asthma	1.57e-05	6.71e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IL2—asthma	1.56e-05	6.68e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IL2—asthma	1.56e-05	6.68e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—IL2—asthma	1.56e-05	6.68e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IL2—asthma	1.54e-05	6.59e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—MMP9—asthma	1.48e-05	6.33e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—MMP9—asthma	1.48e-05	6.33e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—MMP9—asthma	1.48e-05	6.33e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—PTEN—asthma	1.47e-05	6.29e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—PTEN—asthma	1.47e-05	6.29e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—PTEN—asthma	1.47e-05	6.29e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—MMP9—asthma	1.46e-05	6.24e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—PTEN—asthma	1.45e-05	6.2e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—ALB—asthma	1.45e-05	6.19e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IL6—asthma	1.42e-05	6.08e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IL6—asthma	1.42e-05	6.08e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IL6—asthma	1.42e-05	6.08e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IL6—asthma	1.4e-05	5.99e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—NQO1—asthma	1.37e-05	5.87e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ADCY2—asthma	1.34e-05	5.75e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—VEGFA—asthma	1.33e-05	5.68e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—VEGFA—asthma	1.33e-05	5.68e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—VEGFA—asthma	1.33e-05	5.68e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—STAT3—asthma	1.31e-05	5.63e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—STAT3—asthma	1.31e-05	5.63e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—STAT3—asthma	1.31e-05	5.63e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—IL6—asthma	1.31e-05	5.61e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—IL6—asthma	1.31e-05	5.61e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—IL6—asthma	1.31e-05	5.61e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—VEGFA—asthma	1.31e-05	5.6e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—STAT3—asthma	1.29e-05	5.55e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—IL6—asthma	1.29e-05	5.53e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—TGFB1—asthma	1.22e-05	5.21e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—TGFB1—asthma	1.22e-05	5.21e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—TGFB1—asthma	1.22e-05	5.21e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—IL6—asthma	1.21e-05	5.18e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—IL6—asthma	1.2e-05	5.16e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—TGFB1—asthma	1.2e-05	5.14e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—EGFR—asthma	1.19e-05	5.11e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—EGFR—asthma	1.19e-05	5.11e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—EGFR—asthma	1.19e-05	5.11e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—EGFR—asthma	1.18e-05	5.04e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GSTP1—asthma	1.14e-05	4.9e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—HMOX1—asthma	1.13e-05	4.83e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ITPR1—asthma	1.13e-05	4.82e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CAT—asthma	1.11e-05	4.77e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GSTM1—asthma	1.05e-05	4.5e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PLA2G4A—asthma	1.05e-05	4.5e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PPP2CA—asthma	9.68e-06	4.15e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IL6—asthma	9.17e-06	3.93e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—IL6—asthma	9.17e-06	3.93e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IL6—asthma	9.17e-06	3.93e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IL6—asthma	9.04e-06	3.87e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—POMC—asthma	7.43e-06	3.18e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ALB—asthma	6.77e-06	2.9e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—NOS3—asthma	6.48e-06	2.77e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PTGS2—asthma	5.92e-06	2.54e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PTEN—asthma	5.17e-06	2.21e-05	CbGpPWpGaD
